Cargando…
The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
BACKGROUND: Despite the heavy burden and impact of the polycystic ovary syndrome (PCOS) in reproduction and public health, estimates regarding its prevalence at community levels are limited. We aimed to ascertain prevalence of PCOS in a community based sample using the National Institute of Health (...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070632/ https://www.ncbi.nlm.nih.gov/pubmed/21435276 http://dx.doi.org/10.1186/1477-7827-9-39 |
_version_ | 1782201395827441664 |
---|---|
author | Tehrani, Fahimeh Ramezani Simbar, Masoumeh Tohidi, Maryam Hosseinpanah, Farhad Azizi, Fereidoun |
author_facet | Tehrani, Fahimeh Ramezani Simbar, Masoumeh Tohidi, Maryam Hosseinpanah, Farhad Azizi, Fereidoun |
author_sort | Tehrani, Fahimeh Ramezani |
collection | PubMed |
description | BACKGROUND: Despite the heavy burden and impact of the polycystic ovary syndrome (PCOS) in reproduction and public health, estimates regarding its prevalence at community levels are limited. We aimed to ascertain prevalence of PCOS in a community based sample using the National Institute of Health (NIH), the Rotterdam consensus (Rott.) and the Androgen Excess Society (AES) criteria. METHODS: Using the stratified, multistage probability cluster sampling method, 1126 women were randomly selected from among reproductive aged women of different geographic regions of Iran. PCOS were diagnosed using universal assessment of ultrasonographic parameters, hormonal profiles and clinical histories. RESULTS: The mean +/- SD of age of study population was 34.4 +/- 7.6 years. Estimated prevalence of idiopathic hirsutism was 10.9% (95% CI: 8.9-12.9%); 8.3% of women had only oligo/anovulation and 8.0% had only polycystic ovaries. The prevalence of PCOS was 7.1% (95% CI: 5.4-8.8%) using the NIH definition, 11.7% (95% CI: 9.5-13.7%) by AES criteria and 14.6% (95% CI: 12.3-16.9%) using the Rott definition. CONCLUSIONS: At community level, widespread screening of Rotterdam criteria will increase the estimated prevalence of PCOS over twofold. Establishing an explicit and contemporaneous method for definition and screening of each PCOS criteria has important investigational implications and increase the comparability of published research. |
format | Text |
id | pubmed-3070632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30706322011-04-05 The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study Tehrani, Fahimeh Ramezani Simbar, Masoumeh Tohidi, Maryam Hosseinpanah, Farhad Azizi, Fereidoun Reprod Biol Endocrinol Research BACKGROUND: Despite the heavy burden and impact of the polycystic ovary syndrome (PCOS) in reproduction and public health, estimates regarding its prevalence at community levels are limited. We aimed to ascertain prevalence of PCOS in a community based sample using the National Institute of Health (NIH), the Rotterdam consensus (Rott.) and the Androgen Excess Society (AES) criteria. METHODS: Using the stratified, multistage probability cluster sampling method, 1126 women were randomly selected from among reproductive aged women of different geographic regions of Iran. PCOS were diagnosed using universal assessment of ultrasonographic parameters, hormonal profiles and clinical histories. RESULTS: The mean +/- SD of age of study population was 34.4 +/- 7.6 years. Estimated prevalence of idiopathic hirsutism was 10.9% (95% CI: 8.9-12.9%); 8.3% of women had only oligo/anovulation and 8.0% had only polycystic ovaries. The prevalence of PCOS was 7.1% (95% CI: 5.4-8.8%) using the NIH definition, 11.7% (95% CI: 9.5-13.7%) by AES criteria and 14.6% (95% CI: 12.3-16.9%) using the Rott definition. CONCLUSIONS: At community level, widespread screening of Rotterdam criteria will increase the estimated prevalence of PCOS over twofold. Establishing an explicit and contemporaneous method for definition and screening of each PCOS criteria has important investigational implications and increase the comparability of published research. BioMed Central 2011-03-25 /pmc/articles/PMC3070632/ /pubmed/21435276 http://dx.doi.org/10.1186/1477-7827-9-39 Text en Copyright ©2011 Tehrani et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Tehrani, Fahimeh Ramezani Simbar, Masoumeh Tohidi, Maryam Hosseinpanah, Farhad Azizi, Fereidoun The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study |
title | The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study |
title_full | The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study |
title_fullStr | The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study |
title_full_unstemmed | The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study |
title_short | The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study |
title_sort | prevalence of polycystic ovary syndrome in a community sample of iranian population: iranian pcos prevalence study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070632/ https://www.ncbi.nlm.nih.gov/pubmed/21435276 http://dx.doi.org/10.1186/1477-7827-9-39 |
work_keys_str_mv | AT tehranifahimehramezani theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy AT simbarmasoumeh theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy AT tohidimaryam theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy AT hosseinpanahfarhad theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy AT azizifereidoun theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy AT tehranifahimehramezani prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy AT simbarmasoumeh prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy AT tohidimaryam prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy AT hosseinpanahfarhad prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy AT azizifereidoun prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy |